Literature DB >> 25089856

Identification and review of cost-effectiveness model parameters: a qualitative study.

Eva Kaltenthaler1, Munira Essat1, Paul Tappenden1, Suzy Paisley1.   

Abstract

OBJECTIVES: Health economic models are developed as part of the health technology assessment process to determine whether health interventions represent good value for money. These models are often used to directly inform healthcare decision making and policy. The information needs for the model require the use of other types of information beyond clinical effectiveness evidence to populate the model's parameters. The purpose of this research study was to explore issues concerned with the identification and use of information for the development of such models.
METHODS: Three focus groups were held in February 2011 at the University of Sheffield with thirteen UK HTA experts. Attendees included health economic modelers, information specialists and systematic reviewers. Qualitative framework analysis was used to analyze the focus group data.
RESULTS: Six key themes, with related sub-themes, were identified dealing with decisions and judgments; searching methods; selection and rapid review of evidence; team communication; modeler experience and clinical input and reporting methods. There was considerable overlap between themes.
CONCLUSIONS: Key issues raised by the respondents included the need for effective communication and teamwork throughout the model development process, the importance of using clinical experts as well as the need for transparent reporting of methods and decisions.

Entities:  

Mesh:

Year:  2014        PMID: 25089856     DOI: 10.1017/S0266462314000245

Source DB:  PubMed          Journal:  Int J Technol Assess Health Care        ISSN: 0266-4623            Impact factor:   2.188


  4 in total

1.  Identification of Evidence for Key Parameters in Decision-Analytic Models of Cost Effectiveness: A Description of Sources and a Recommended Minimum Search Requirement.

Authors:  Suzy Paisley
Journal:  Pharmacoeconomics       Date:  2016-06       Impact factor: 4.981

2.  How Qualitative Methods Can be Used to Inform Model Development.

Authors:  Samantha Husbands; Susan Jowett; Pelham Barton; Joanna Coast
Journal:  Pharmacoeconomics       Date:  2017-06       Impact factor: 4.981

3.  Understanding and Identifying Key Issues with the Involvement of Clinicians in the Development of Decision-Analytic Model Structures: A Qualitative Study.

Authors:  Samantha Husbands; Susan Jowett; Pelham Barton; Joanna Coast
Journal:  Pharmacoeconomics       Date:  2018-12       Impact factor: 4.981

Review 4.  Reinforcing Collaboration and Harmonization to Unlock the Potentials of Advanced Therapy Medical Products: Future Efforts Are Awaited From Manufacturers and Decision-Makers.

Authors:  Tingting Qiu; Shuyao Liang; Yitong Wang; Claude Dussart; Borislav Borissov; Mondher Toumi
Journal:  Front Public Health       Date:  2021-11-25
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.